<DOC>
	<DOCNO>NCT00004209</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . It yet know whether three course combination chemotherapy effective six course combination chemotherapy non-small cell lung cancer . PURPOSE : Randomized phase III trial compare effectiveness three course combination chemotherapy six course combination chemotherapy treat patient stage IIIB stage IV non-small cell lung cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Stage IIIB Stage IV Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare duration symptom control , time disease progression , survival , quality life patient stage IIIB IV non-small cell lung cancer treat 3 versus 6 course mitomycin , vinblastine , cisplatin . OUTLINE : This randomize , multicenter study . Patients stratified stage disease ( stage IIIB v IV ) . Patients randomize 1 2 treatment arm : Arm I : Patients receive cisplatin IV 4 hour , mitomycin IV , vinblastine IV day 1 . Treatment repeat every 3 week 3 course absence disease progression unacceptable toxicity . Mitomycin administer course 3 . Arm II : Patients receive chemotherapy arm I . Treatment repeat every 3 week 6 course absence disease progression unacceptable toxicity . Mitomycin administer course 3 5 . Quality life assess completion 3 course chemotherapy patient arm I completion 4 , 5 , 6 course arm II . Patients may receive radiotherapy begin completion chemotherapy . PROJECTED ACCRUAL : A total 310 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven stage IIIB IV nonsmall cell lung cancer eligible surgery radical radiotherapy PATIENT CHARACTERISTICS : Age : 18 Performance status : ZubrodWHO 02 Life expectancy : Not specify Hematopoietic : Hemoglobin great 10 g/dL WBC great 3,000/mm3 Platelet count great 100,000/mm3 Hepatic : Liver function test great 2 time normal ( unless due metastatic disease ) Renal : Creatinine clearance great 60 mL/min EDTA clearance great 60 mL/min Other : No serious , uncontrolled , concurrent medical illness PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior conventional chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>